← Evidence map

RetractedArticleOncology letters2022

miR-143-5p suppresses breast cancer progression by targeting the HIF-1α-related GLUT1 pathway.

Jia Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35350590